Clinical Trial Update: A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating two doses of the Alzheimer's imaging tracer 18F-AV-45 (florbetapir F-18) in Alzheimer's disease patients and healthy volunteers; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Florbetapir F-18 (florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED | Results posted: 2012-05-02